PRESS RELEASE Publication of an insider information according to article 17 MAR With a cash capital increase, the CytoTools AG creates the conditions for realisation of the medical product strategy.

Darmstadt, 21st April 2017 - Within the scope of a cash capital increase, the CytoTools AG, under partial utilisation of the approved capital, with the exclusion of subscription rights, issued 100,000 newly created shares, which were subscribed by institutional investors at an issue price of 14.00 EUR each. The gross proceeds from this financing round of 1,400,000.00 EUR is to be used for the medical product development, in order to extend the potential of the wound healing active substance DermaPro® to medical products. The share capital of the company thus increases from 2,000,000.00 EUR by 100,000.00 EUR to 2,100,000.00 EUR.

End of the ad hoc announcement

This press release contains specific future oriented statements. These reflect the opinion of CytoTools on the date of this release. The actual results achieved by CytoTools could substantially deviate from the future- oriented statements made. CytoTools is not obligated to update these future-oriented statements.

About CytoTools

CytoTools AG is a German biotechnology company focused on translating fundamental biology research on the mechanisms of cell growth and programmed cell death into unique therapies that are designed to treat the cause of the disease rather than the symptoms. The Company has developed a robust and diverse pipeline of disease modifying therapies that comprise proprietary small molecules and biologics. These have the potential to provide new treatment options in dermatology, cardiology and angiology, urology and oncology. CytoTools AG is structured as an investment and holding company and as such holds investments in its subsidiaries DermaTools Biotech GmbH (57%) and CytoPharma GmbH (42%).

Contact:

CytoTools AG

Dr. Mark-André Freyberg Klappacher Str. 126

D-64285 Darmstadt

Tel.: +49-6151-95158-12

Fax: +49-6151-95158-13

E-Mail: freyberg@cytotools.de

CytoTools AG published this content on 25 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 25 April 2017 11:27:17 UTC.

Original documenthttp://www.cytotools.de/index.php/files/download/281

Public permalinkhttp://www.publicnow.com/view/B9C9AF2374E834176B2C4A131832182983FC85FD